We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+1.13%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$10.4B
AUM Growth
-$279M
(-2.6%)
Cap. Flow
-$218M
Cap. Flow
% of AUM
-2.1%
Top 10 Holdings %
Top 10 Hldgs %
17.29%
Holding
1,364
New
413
Increased
268
Reduced
302
Closed
358
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Adobe
ADBE
|
+$105M |
| 2 |
EMC
EMC CORPORATION
EMC
|
+$103M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$97.6M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$77.4M |
| 5 |
Humana
HUM
|
+$71.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$125M |
| 2 |
Perrigo
PRGO
|
+$103M |
| 3 |
AGN
Allergan plc
AGN
|
+$99.6M |
| 4 |
Pfizer
PFE
|
+$90M |
| 5 |
Viatris
VTRS
|
+$88.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 15.63% |
| 2 | Healthcare | 15.57% |
| 3 | Communication Services | 13.26% |
| 4 | Technology | 11.56% |
| 5 | Financials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Pegasystems
PEGA
$4.41B
| $478K | ﹤0.01% |
+37,686
| New | +$452K |
|
|
ISBC
852
DELISTED
Investors Bancorp, Inc.
ISBC
| $478K | ﹤0.01% |
+41,076
| New | +$473K |
|
|
SINA
853
DELISTED
Sina Corp
SINA
| $477K | ﹤0.01% |
10,064
| – | – |
|
|
IPHS
854
DELISTED
Innophos Holdings, Inc.
IPHS
| $477K | ﹤0.01% |
15,416
-88,950
| -85% | -$2.45M |
|
855
Merit Medical Systems
MMSI
$4.43B
| $473K | ﹤0.01% |
+25,570
| New | +$443K |
|
|
WIRE
856
DELISTED
Encore Wire Corp
WIRE
| $470K | ﹤0.01% |
+12,078
| New | +$437K |
|
857
Frontline
FRO
$8.75B
| $467K | ﹤0.01% |
55,853
-199,270
| -78% | -$1.92M |
|
|
GTS
858
DELISTED
Triple-S Management Corporation
GTS
| $467K | ﹤0.01% |
+19,763
| New | +$443K |
|
859
Dick's Sporting Goods
DKS
$18.4B
| $463K | ﹤0.01% |
+9,892
| New | +$402K |
|
|
TERP
860
DELISTED
TerraForm Power, Inc
TERP
| $458K | ﹤0.01% |
+53,038
| New | +$494K |
|
861
Kohl's
KSS
$2.03B
| $452K | ﹤0.01% |
+9,707
| New | +$456K |
|
862
Crown Castle
CCI
$32.7B
| $450K | ﹤0.01% |
+5,207
| New | +$441K |
|
863
ING
ING
$93.8B
| $449K | ﹤0.01% |
+37,614
| New | +$451K |
|
864
State Street Utilities Select Sector SPDR ETF
XLU
$24.1B
| $445K | ﹤0.01% |
+17,932
| New | +$414K |
|
|
BLUE
865
DELISTED
bluebird bio
BLUE
| $441K | ﹤0.01% |
800
-12,203
| -94% | -$7.49M |
|
|
MRC
866
DELISTED
MRC Global
MRC
| $438K | ﹤0.01% |
+33,359
| New | +$384K |
|
867
TransDigm Group
TDG
$69.2B
| $436K | ﹤0.01% |
1,977
-54,267
| -96% | -$11.9M |
|
|
GIMO
868
DELISTED
Gigamon Inc.
GIMO
| $435K | ﹤0.01% |
14,013
-39,265
| -74% | -$1.02M |
|
869
Yelp
YELP
$1.38B
| $429K | ﹤0.01% |
+21,601
| New | +$442K |
|
|
VRTU
870
DELISTED
Virtusa Corporation
VRTU
| $426K | ﹤0.01% |
+11,379
| New | +$431K |
|
|
RTN
871
DELISTED
Raytheon Company
RTN
| $425K | ﹤0.01% |
3,464
-300,120
| -99% | -$37M |
|
|
GAS
872
DELISTED
AGL Resources Inc
GAS
| $422K | ﹤0.01% |
+6,474
| New | +$417K |
|
|
ICPT
873
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $420K | ﹤0.01% |
+3,266
| New | +$386K |
|
874
Mettler-Toledo International
MTD
$26.8B
| $418K | ﹤0.01% |
1,213
+146
| +14% | +$47K |
|
875
Vornado Realty Trust
VNO
$7.47B
| $418K | ﹤0.01% |
+5,472
| New | +$397K |
|
Similar funds
Marshall Wace's Q1 2016 Portfolio in Review
As of Q1 2016, Marshall Wace held 1,364 positions worth $10.4B, down 2.6% from $10.7B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Marshall Wace's Q1 2016 filing shows 413 new, 268 increased, 302 reduced and 358 closed positions. Its largest new stake was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M. The largest sale was Bristol-Myers Squibb, an estimated $125M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 16% of assets, up from 12% a quarter earlier, followed by Healthcare and Communication Services.
- Marshall Wace's largest Q1 2016 buy was iShares MSCI Emerging Markets ETF: 3,149,620 shares worth $108M.
- Marshall Wace added most to Adobe in Q1 2016, an estimated $105M increase.
- Marshall Wace's biggest Q1 2016 reduction was Bristol-Myers Squibb, cutting an estimated $125M.
- Marshall Wace fully exited Perrigo in Q1 2016, selling an estimated $103M.
- Marshall Wace's ten largest holdings make up 17% of its $10.4B portfolio in Q1 2016.
- Marshall Wace opened 413 new positions and closed 358 in Q1 2016.
- Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $10.4B.
Based on Marshall Wace's 13F filing for Q1 2016, filed 13 May 2016.